Cytokinetics
CYTK
#2280
Rank
S$10.40 B
Marketcap
S$85.10
Share price
-1.31%
Change (1 day)
26.15%
Change (1 year)

Cytokinetics (CYTK) - Net assets

Net assets on the balance sheet as of September 2025 : -S$0.68 Billion

According to Cytokinetics 's latest financial reports the company has -S$0.68 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cytokinetics - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-S$0.19 Billion-63.94%
2023-12-31$-S$0.52 Billion252.72%
2022-12-31$-S$0.15 Billion-143.88%
2021-12-31$S$0.32 B119.79%
2020-12-31$S$0.14 B-1117.28%
2019-12-31$-S$14.75 Million-141.62%
2018-12-31$S$35.42 M-75.88%
2017-12-31$S$0.14 B7.57%
2016-12-31$S$0.13 B40.76%
2015-12-31$S$97.02 M-20.24%
2014-12-31$S$0.12 B76.36%
2013-12-31$S$68.97 M-19.52%
2012-12-31$S$85.7 M37.37%
2011-12-31$S$62.39 M-31.31%
2010-12-31$S$90.83 M-36.21%
2009-12-31$S$0.14 B100.08%
2008-12-31$S$71.17 M-50.5%
2007-12-31$S$0.14 B-11.8%
2006-12-31$S$0.16 B33.1%
2005-12-31$S$0.12 B-30.2%
2004-12-31$S$0.17 B-212.22%
2003-12-31$-S$0.16 Billion48.73%
2002-12-31$-S$0.11 Billion52.04%
2001-12-31$-S$69.15 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
S$1.23 B-282.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-S$30.21 Million-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-S$0.25 Billion-64.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.46 B-1,945.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$0.52 B-177.64%๐Ÿ‡บ๐Ÿ‡ธ USA